1. Home
  2. MBAI vs NXGL Comparison

MBAI vs NXGL Comparison

Compare MBAI & NXGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Check-Cap Ltd. Ordinary Share

MBAI

Check-Cap Ltd. Ordinary Share

N/A

Current Price

$1.65

Market Cap

10.6M

Sector

N/A

ML Signal

N/A

Logo NexGel Inc

NXGL

NexGel Inc

HOLD

Current Price

$0.67

Market Cap

9.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MBAI
NXGL
Founded
2004
1997
Country
Israel
United States
Employees
N/A
19
Industry
Medical/Dental Instruments
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.6M
9.8M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
MBAI
NXGL
Price
$1.65
$0.67
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$2.00
AVG Volume (30 Days)
49.9K
231.4K
Earning Date
05-08-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$39.28
Revenue Next Year
N/A
$42.29
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.31
$0.65
52 Week High
$3.92
$3.25

Technical Indicators

Market Signals
Indicator
MBAI
NXGL
Relative Strength Index (RSI) 49.18 28.51
Support Level $1.38 N/A
Resistance Level $1.89 $2.73
Average True Range (ATR) 0.14 0.13
MACD -0.01 -0.02
Stochastic Oscillator 30.77 4.93

Price Performance

Historical Comparison
MBAI
NXGL

About MBAI Check-Cap Ltd. Ordinary Share

Check-Cap Ltd is a clinical-stage medical diagnostics company engaged in the development of an ingestible imaging capsule that utilizes low-dose X-rays for the detection and imaging of colonic polyps and colorectal cancers, or CRC. The company is developing C-Scan, the first capsule-based system for preparation-free, colorectal cancer screening. Its scanning capsule will be swallowed and propelled by natural motility through the gastrointestinal tract and excreted naturally with no need for retrieval for data collection. The operations of the company are presently located in Israel, but it currently expects to market products in the United States, Europe, Israel and Japan.

About NXGL NexGel Inc

NexGel Inc manufactures high water content, electron beam cross-linked, aqueous polymer hydrogels, or gels, used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company specializes in custom gels by capitalizing on proprietary manufacturing technologies. The gels and consumer products are manufactured using proprietary and non-proprietary mixing, coating and cross-linking technologies.

Share on Social Networks: